Compounds > selenocysteine

selenocysteine and ER-Negative PR-Negative HER2-Negative Breast Cancer

selenocysteine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Accardo, M; Budillon, A; Capone, F; Costantini, S; Guerriero, E; Marino, FZ; Nunziata, C; Orditura, M; Polo, A; Sorice, A1

Other Studies

1 other study(ies) available for selenocysteine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer.
    Scientific reports, 2019, 11-06, Volume: 9, Issue:1

    Topics: Amino Acid Sequence; Female; Gene Amplification; Humans; Phosphotransferases; Protein Stability; Selenocysteine; Triple Negative Breast Neoplasms

2019